Nasogastric Tube
0
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Gravitas MedicalCA - San Francisco
3 programsEntarik Feeding Tube SystemN/A1 trial
Gravitas FT and Gravitas FT Monitor guidanceN/A1 trial
Nasogastric TubeN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
Gravitas MedicalGravitas FT and Gravitas FT Monitor guidance
Gravitas MedicalEntarik Feeding Tube System
Gravitas MedicalNasogastric Tube
Clinical Trials (3)
Total enrollment: 161 patients across 3 trials
Gravitas Feeding Tube System Placement Validation in Neonates
Start: Oct 2023Est. completion: Dec 2026100 patients
N/AActive Not Recruiting
Entarik Feeding Tube System Placement in Adult ICU
Start: May 2023Est. completion: Jan 202545 patients
N/ATerminated
Gravitas Feeding Tube System Placement in Neonates
Start: Nov 2022Est. completion: Aug 202316 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.